XLB•XLB•| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Miss | $1.4 billion | $1.46 billion (6 analysts) |
| Q2 Adjusted EPS | Miss | $3.87 | $3.99 (7 analysts) |
| Q2 EPS | $2.45 | ||
| Q2 Adjusted Net Income | Miss | $300 million | $315.67 million (3 analysts) |
| Q2 Net Income | $198 million | ||
| Q2 Adjusted EBITDA | Miss | $577 million | $583.79 million (6 analysts) |
| Q2 Basic EPS | $2.56 |
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell".
The average consensus recommendation for the commodity chemicals peer group is "buy".
The stock recently traded at 8 times the next 12-month earnings versus a P/E of 13 three months ago.
Canada methanol producer's Q2 revenue, adjusted EPS and EBITDA missed analyst expectations.
Record adjusted EBITDA was driven by higher realized prices and strong North American output.
The company indefinitely idled the Titan plant in Trinidad, recording a $115 million asset impairment charge.
Methanex expects 2026 methanol production of about 9.0 million tonnes and ammonia at 0.3 million tonnes.
The company expects July-August average realized price between $460 and $485 per tonne.
Methanex expects lower adjusted EBITDA in Q3 due to a lower realized price and similar sales.
